本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

93.55
+1.351.46%
盤前94.460.9125+0.98%05:10 EDT
成交量:92.70萬
成交額:8,692.27萬
市值:61.94億
市盈率:-46.22
高:95.46
開:92.70
低:92.19
收:92.20
52周最高:115.52
52周最低:14.89
股本:6,620.97萬
流通股本:5,688.40萬
量比:1.44
換手率:1.63%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
淨資產收益率:-18.23%
總資產收益率:-12.95%
市淨率:5.57
市盈率(LYR):-50.61

資料載入中...

2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/21

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/23

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

重要事件披露

Form 8-K - Current report
2024/09/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/14

重要事件披露

Form 8-K - Current report
2024/09/07

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/27

重要事件披露

Form 8-K - Current report
2024/08/27

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/08/23

重要事件披露

Form 8-K - Current report
2024/08/16

重要事件披露

Form 8-K - Current report